Understand the impact of IND delays on biotechnology companies and how they affect early-stage development and funding.

Earnings call CAREL Industries reported FY 2025 revenue of EUR 629 million, up 8.7% YoY (10.6% organic), with Q4 organic growth accelerating to 16.9%. Adjusted EBITDA margin reached 20%, and net ...

Market Trends: Market sentiment may lean cautiously optimistic today, Aries, with investors seemingly favouring quality over speculation. You might notice defensive sectors holding ground while growth ...

F10 Antiseptic Wound Spray with Insecticide received the EUA based on scientific evidence available. The FDA announced earlier this week it issued an Emergency Use Authorization (EUA) for benzalkonium ...